Swiss National Bank Sangamo Therapeutics, Inc Transaction History

Swiss National Bank

$150 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$1.66 - $3.67 $34,196 - $75,602	-20,600 Reduced 6.41%	300,660 $529,000
Q4 2022 Feb 08, 2023	BUY	$2.77 - $5.07 $78,945 - $144,495	28,500 Added 9.73%	321,260 $1.01 Million
Q1 2022 May 09, 2022	BUY	$5.23 - $7.82 $118,198 - $176,732	22,600 Added 8.37%	292,760 $1.7 Million
Q3 2021 Nov 08, 2021	BUY	$9.01 - $12.01 $16,218 - $21,618	1,800 Added 0.67%	270,160 $2.43 Million
Q2 2021 Aug 06, 2021	SELL	$10.17 - $12.64 $64,071 - $79,632	-6,300 Reduced 2.29%	268,360 $3.21 Million
Q1 2021 May 07, 2021	BUY	$10.88 - $17.05 $35,904 - $56,265	3,300 Added 1.22%	274,660 $3.44 Million
Q3 2020 Nov 09, 2020	BUY	$9.38 - $12.48 $118,188 - $157,248	12,600 Added 4.87%	271,360 $2.56 Million
Q2 2020 Aug 05, 2020	BUY	$6.21 - $11.83 $210,519 - $401,037	33,900 Added 15.08%	258,760 $2.32 Million
Q1 2020 May 08, 2020	BUY	$5.05 - $8.85 $17,170 - $30,090	3,400 Added 1.54%	224,860 $1.43 Million
Q4 2019 Feb 06, 2020	BUY	$8.03 - $11.7 $40,953 - $59,670	5,100 Added 2.36%	221,460 $1.85 Million
Q3 2019 Nov 12, 2019	BUY	$9.05 - $12.22 $54,300 - $73,320	6,000 Added 2.85%	216,360 $1.96 Million
Q2 2019 Aug 02, 2019	BUY	$8.75 - $13.03 $212,625 - $316,629	24,300 Added 13.06%	210,360 $2.27 Million
Q1 2019 May 10, 2019	BUY	$7.72 - $12.81 $48,636 - $80,703	6,300 Added 3.5%	186,060 $1.78 Million
Q4 2018 Feb 13, 2019	BUY	$9.51 - $16.6 $25,677 - $44,820	2,700 Added 1.52%	179,760 $2.06 Million
Q3 2018 Nov 08, 2018	BUY	$13.05 - $19.05 $50,895 - $74,295	3,900 Added 2.25%	177,060 $3 Million
Q2 2018 Aug 09, 2018	BUY	$13.9 - $19.8 $386,420 - $550,440	27,800 Added 19.12%	173,160 $2.46 Million
Q1 2018 May 04, 2018	BUY	$16.7 - $26.35 $48,430 - $76,415	2,900 Added 2.04%	145,360 $2.76 Million
Q4 2017 Feb 07, 2018	BUY	$11.6 - $17.35 $62,640 - $93,690	5,400 Added 3.94%	142,460 $2.34 Million
Q3 2017 Nov 03, 2017	BUY	$8.4 - $15.0 $1.15 Million - $2.06 Million	137,060	137,060 $2.06 Million

Others Institutions Holding SGMO

# of Institutions

111

Shares Held

56.4M

Call Options Held

576K

Put Options Held

1.17M

Wasatch Advisors Inc Salt Lake City, UT

19.4M
Shares

$22.4 Million
0.08% of portfolio
Vanguard Group Inc Valley Forge, PA

9.6M
Shares

$11 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.85M
Shares

$5.58 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.7M
Shares

$5.41 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.35M
Shares

$2.71 Million
0.0% of portfolio

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $180M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account